My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

96.06 -2.41 (-2.45%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rhythm Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

5 Analysts Assess Rhythm Pharmaceuticals: What You Need To Know ↗

April 10, 2024

Via Benzinga

Analyst Expectations For Rhythm Pharmaceuticals's Future ↗

February 22, 2024

Via Benzinga

The Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Experts ↗

January 04, 2024

Via Benzinga

Analyst Expectations for Rhythm Pharmaceuticals's Future ↗

December 07, 2023

Via Benzinga

Rare Genetic Diseases Of Obesity-Focused Rhythm Pharma's Bardet-Biedl Syndrome Drug Meets Primary Goal In Pediatric Trial ↗

December 06, 2023

During the R&D event for investors, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) released new topline data from its Phase 3 pediatrics trial evaluating one year of setmelanotide in patients aged two and...

Via Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Rhythm Pharmaceuticals: Here's What You Need To Know ↗

October 10, 2023

Via Benzinga

Rhythm Pharmaceuticals's Return On Capital Employed Overview ↗

May 08, 2023

Via Benzinga

A Preview Of Rhythm Pharmaceuticals's Earnings ↗

May 01, 2023

Via Benzinga

Expert Ratings for Rhythm Pharmaceuticals ↗

March 02, 2023

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Rhythm Pharmaceuticals's Return On Capital Employed Overview ↗

December 06, 2022

Via Benzinga

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

Preview: Rhythm Pharmaceuticals's Earnings ↗

February 21, 2024

Via Benzinga

Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) ↗

January 25, 2024

Via Benzinga

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023 ↗

August 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 01, 2023

Via Benzinga

Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday ↗

August 01, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...

Via Benzinga

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

What Will Amgen Buy Next? ↗

June 29, 2023

The biotech could pursue these two budget-friendly targets.

Via The Motley Fool

3 Breakout Growth Stocks to Buy for the Long Haul ↗

January 09, 2023

These three have had big-time share gains backed up by breakthrough science.

Via The Motley Fool

20 Favorite Biotech & Medical Stocks For 2023 ↗

December 28, 2022

The way these stocks are setting up, many of them look great and will be at the forefront this coming year.

Via Talk Markets

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 15, 2022

Via Benzinga

Why Is Rhythm Pharmaceuticals Stock Down Today? ↗

September 15, 2022

Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) shares are trading lower Thursday morning after the company priced its public offering of 4.8 million shares of common stock at $26 per share.

Via Benzinga

Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday ↗

September 16, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 15, 2022

Via Benzinga

Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session ↗

September 15, 2022

Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...

Via Benzinga

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket ↗

September 15, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 15, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.